Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intravenous ketamine during anesthesia induction for CABG surgery
IRCT20231021059795N1Phase 3Completed
- Sponsor
- Iran University of Medical Sciences
- Start
- Mar 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, triple-blind trial in delirium comparing Ketamine with Placebo (2 arms). Primary endpoints: Incidence of delirium at 24 hours in ICU and Incidence of delirium at 48 hours in ICU. Started Mar 2024; status: completed.
02
Drugs
ketamine
03
Conditions
delirium
Beyond the preview
Go deeper on IRCT20231021059795N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20231021059795N1.